Postpartum Infectious Morbidity in Cesarean Section Delivery Clinical Trial
Official title:
Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery
This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | October 2017 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: 1. Women undergoing cesarean delivery, both elective and non-elective. 2. Rupture of membranes and labor contractions will be allowed. Exclusion Criteria: 1. Unknown outcome from the patient. 2. Refusing to participate in the study from the admission conse 3. Allergy to antibiotics. 4. Any visible infection. |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Raghda Gamal Mohamed |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | role of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity | 2 weeks following cesarean section | Yes |